Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
GLP-1RA in Different HFpEF Phenotypes
Author(s): Aleksandra Bykova , Maria Serova , Maria Chashkina , et al Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Mineralocorticoid Receptor Antagonists in Heart Failure
Author(s): Rishi Sethi , Pravesh Vishwakarma , Akshyaya Pradhan Added: 1 year ago

MI/ACS

Heart Failure
Mattias Duytschaever
Job title: Cardiologist
Dr Mattias Duytschaever is a cardiologist and electrophysiology specialist based in Belgium. He is internationally recognised for his expertise in atrial fibrillation and interventional electrophysiology. He combines clinical practice with academic research and teaching, holding a longstanding professorship in electrophysiology at the University of Ghent.Academic HistoryDr Duytschaever obtained… View more
Izabella Uchmanowicz
Research Area(s) / Expertise:

Heart Failure

 Job title: Professor
Dr Izabella Uchmanowicz is an Editorial Board member ofCardiac Failure Review. Academic History Dr Uchmanowicz studied for her Master’s degree in Nursing at the Wroclaw Medical University, prior to studying for her Bachelor of Applied Science in Nursing at New York University in 1997. Career Overview Prof Uchmanowicz is currently a Professor and Chief Nurse at the Institute of Heart… View more
Risk Prediction of CVD in the Asia-Pacific Region
Author(s): SCORE2 Asia-Pacific Writing Group , Steven HJ Hageman , Zijuan Huang , et al Added: 1 year ago

Demographic

Heart Failure
TTR Therapies Show Delayed Mortality Benefit in ATTR-CM
Added: 3 months ago Source:  Radcliffe Cardiology
Therapies for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), including transthyretin (TTR) stabilisers and silencers, have demonstrated a mortality benefit in randomised trials. However, the timing of this benefit has been a subject of debate. A new analysis of three major outcomes trials has evaluated this time course, revealing a consistent pattern across different treatments… View more

Heart Failure
Delayed ATTR-CM Diagnosis Common in HF Patients
Added: 3 months ago Source:  Radcliffe Cardiology
A new study has revealed significant delays in the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) following an initial diagnosis of heart failure (HF), with the median time to diagnosis exceeding one year.¹ Timely identification of ATTR-CM is critical to reduce morbidity and mortality, as effective treatments are available.²MethodologyThis retrospective cohort study analysed data… View more

Heart Failure
Aaron Isaacs
Personal History Dr Aaron Isaacs is based in the Netherlands, where he works in the Department of Physiology, Cardiovascular Research Institute Maastricht at Maastricht University. Academic History Dr Aaron Isaacs completed his baccalaureate degree at the University of California, Berkeley in 1994. In 2002, he moved to the Netherlands, where he embarked on his PhD studies in genetic… View more
Susan Dent
Research Area(s) / Expertise:

Cardio-oncology

 Job title: President IC-OS and Co-Director Cardio-Oncology
Dr. Dent attended McMaster University Medical School in Hamilton, Ontario, Canada and completed her residency training in Internal Medicine and Medical Oncology at the Ottawa Hospital, University of Ottawa, Ontario, Canada. She subsequently completed a post graduate research fellowship in clinical trials at the Canadian Cancer Trials Group (CCTG) in Kingston, Ontario, and was appointed as a staff… View more
Isabella Tan
Job title: Research Fellow
Personal History Dr Isabella Tan is a software programmer turned cardiovascular research scientist. She is a Research Fellow at the Macquarie Medical School, Macquarie University, Sydney.2 She enjoys watching Japanese anime and reading manga. In addition to English, she speaks Cantonese and Mandarin.1, 4 Academic History In 2003, Dr Tan graduated from the University of New South… View more